Kristin Meliambro is a Nephrology physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 47 publications with 1,501 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Gustave L Levy Pl
New York, NY 100296504
Telephone
212-987-7208Registry record last updated 14 May 2015.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Other
52.8%Phosphate Binder52.8%Sevelamer Carbonate100%Part D<11 patientsCardiovascular
47.2%Calcium channel blocker47.2%Nifedipine Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- KIBRA-induced biomechanical changes and therapeutic targeting in podocytes
Icahn School of Medicine at Mount Sinai
FY2026$508,736R01DK135999 - Mount Sinai Health System Kidney Precision Medicine Project
Icahn School of Medicine at Mount Sinai
FY2026$374,999U01DK133093 - KIBRA-induced biomechanical changes and therapeutic targeting in podocytes
Icahn School of Medicine at Mount Sinai
FY2025$508,736R01DK135999
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Podocyte YAP and TAZ hyperactivation drives glomerular epithelial proliferative diseases in mice and humans
Science Translational Medicine
2025 - Liquid Biopsy-Multiomics Link Adhesion Pathway Dysregulation to Kidney Injury Severity
Kidney International Reports
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”